Dr. Todd Mereniuk, MD, PhD

Dr. Mereniuk practices at Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care.

Dr. Mereniuk's NPI, 1477917409, was assigned on April 6, 2016. Dr. Mereniuk graduated from Tulane University School of Medicine in 2016. Dr. Mereniuk holds Mississippi license 28747.

Dr. Mereniuk's primary practice is Baptist Memorial Hospital-North Mississippi, at 1100 Belk Blvd, Oxford, MS 38655 in Lafayette County. The practice phone is (662) 232-8100.

Dr. Mereniuk's primary practice is Baptist Memorial Hospital-North Mississippi in Oxford, Mississippi, part of Baptist Memorial Health Care. Dr. Mereniuk is also affiliated with Baptist Memorial Hospital-Union County. Dmand AI also links Dr. Mereniuk to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mereniuk practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mereniuk's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mereniuk is licensed in Mississippi.

CMS data shows 4,737 Medicare services from Dr. Mereniuk across 15 procedure codes in 2024, for 227 Medicare patients. Medicare paid $263,292 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 227 Medicare patients who saw Dr. Mereniuk in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mereniuk's median patient age at 74, with 32% women.

In 2024, Dr. Mereniuk wrote 221 Medicare Part D claims for 90 patients. 95% of them were for generic drugs. CMS names the drug for 140 of them, across 5 drugs with 11 or more claims each, at $1,031 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Mereniuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Mereniuk, published from 2012 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Cell Line, Tumor, DNA Repair Enzymes and Lung Neoplasms. Dr. Mereniuk's most frequent co-authors are Ryan Matthew Rhome, MD, PhD, Namita Agrawal, MD and Jordan Alexander Holmes, MD.

CMS Open Payments shows 26 general payments to Dr. Mereniuk from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $103.

Dr. Mereniuk graduated from Tulane University School of Medicine in 2016.